Sales Are Strong for Glaxoâs Weight-Loss Product
108424
Desperate for a cure for fat, consumers have purchased more than two million starter packages of the new weight-loss product Alli since it launched four months ago.
393883
Schering continues its strong sales and earnings growth.
70902
An experimental Sanofi-Aventis diet drug helped people lose much more weight than a placebo in an eagerly anticipated two-year trial, researchers said on Tuesday.
449256
GlaxoSmithKline PLC, the world's second-largest drug maker, began a campaign to challenge a report that linked its diabetes drug Avandia to heart risks and caused its stock to decline 11 percent in the eight days through Tuesday. The shares rose yesterday.
738801
SAN DIEGO -- A new obesity wonder pill could become one of the best selling drugs on the market if it lives up to its clinical trials.
548453
Pharmaceutical maker Abbott Laboratories said its profit growth was driven by strong sales of migraine and Crohnâs disease treatments.
737619
The president of U.S. pharmaceuticals at GlaxoSmithKline Plc , Chris Viehbacher, said on Wednesday it was too early to write off the diabetes drug Avandia, which he said could once again return to annual sales of more than $3 billion.
720081
The leading drugstore retailer is leveraging prescription sales to produce record results.
389904
LOS ANGELES (CBS.MW) - US-traded shares of GlaxoSmithKline were up Thursday as the drugmaker reported a settlement of a lawsuit filed by New York state over disclosure of Paxil test results on minors.
360150
Eyeing a potential gold mine in the global obesity epidemic, the pharmaceutical industry has launched a massive drive to develop new diet pills and an intense campaign to persuade
81672
The pharmaceutical giant is selling its pain relievers and other consumer products.
78838
Diageo, the world's biggest maker of alcoholic drinks, has said that its net profit surged by 42 percent to 1.908 billion pounds during its financial year, boosted by strong sales in the United States.
580574
Nov. 9, 2004 (New Orleans) -- The experimental diet drug Accomplia not only takes off weight and reduces waist size, it also has staying power.
426972
A new anti-obesity drug that works in  the same way as Sanofi-Aventis's Acomplia has advanced in  clinical trials, triggering a $25 million payment to Belgian  drugs, chemicals and plastics maker Solvay.
644769
Christopher Lemley is a marketing professor at Georgia State University who has seen it all when it comes to consumer advertising of prescription drugs. Yet even he was impressed when GlaxoSmithKline sent him a free pillowcase.
504002
The company posted strong second-quarter sales, and an acquisition could help long-term results.
764715
British pharmaceutical giant GlaxoSmithKline said Wednesday that third-quarter profits fell owing to fierce competition from generic drugs and sliding sales of controversial diabetes drug Avandia.